JNJ 8-K 2026-10-13

JOHNSON & JOHNSON (JNJ) 8-K dated 2026-10-13 — accession 0000200406-26-000189. This URL is the filing, not the JNJ hub.

JOHNSON & JOHNSON (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.

JNJ: SECURITIES AND EXCHANGE COMMISSION

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported JNJ revenue for 2025-12-28 was $94.19B. Net income was $26.80B. Revenue was up 6.0% from 2024-12-29 to 2025-12-28. JNJ currently screens at market cap $375.37B and trailing P/E 28.8.

Not investment advice. The JNJ SEC hub lists recent forms. The stock page is the research view.